Zhang Jianqin, Wu Chuxuan, Gao Li, Du Guanhua, Qin Xuemei
Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China.
Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, P. R. China.
Adv Pharmacol. 2020;87:89-112. doi: 10.1016/bs.apha.2019.08.002. Epub 2019 Dec 18.
Decoctions prepared from the roots of Astragali Radix are known as "Huangqi" and are widely used in traditional Chinese medicine for treatment of viral and bacterial infections, inflammation, as well as cancer. Astragaloside IV (AS-IV), one of the major compounds from the aqueous extract of Astragalus membranaceus, is a cycloartane-type triterpene glycoside chemical. To date, many studies in cellular and animal models have demonstrated that AS-IV possesses potent protective effects in cardiovascular, lung, kidney and brain. Based on studies over the past several decades, this review systematically summarizes the pharmacological effects, pharmacokinetics and the toxicity of AS-IV. We analyze in detail the pharmacological effects of AS-IV on neuroprotection, liver protection, anti-cancer and anti-diabetes, attributable to its antioxidant, anti-inflammatory, anti-apoptotic properties, and the roles in enhancement of immunity, attenuation of the migration and invasion of cancer cells and improvement of chemosensitivity of chemotherapy drugs. In addition, the latest developments in the combination of AS-IV and other active ingredients of traditional Chinese medicine or chemical drugs are detailed. These pharmacological effects are associated with multiple signaling pathways, including the Raf-MEK-ERK pathway, EGFR-Nrf2 signaling pathway, Akt/PDE3B signaling pathway, AMPK signaling pathway, NF-κB signaling pathway, Nrf2 antioxidant signaling pathways, PI3K/Akt/mTOR signaling pathway, PKC-α-ERK1/2-NF-κB pathway, IL-11/STAT3 signaling pathway, Akt/GSK-3β/β-catenin pathway, JNK/c-Jun/AP-1 signaling pathway, PI3K/Akt/NF-κB pathway, miRNA-34a/LDHA pathway, Nox4/Smad2 pathway, JNK pathway and NF-kB/PPARγ pathway. This review will provide an overall understanding of the pharmacological functions of astragaloside IV on neuroprotection, liver protection, anti-cancer and anti-diabetes. In light of this, AS-IV will be a potent alternative therapeutic agent for treatment of the above mentioned diseases.
黄芪根制成的汤剂被称为“黄芪”,在传统中医中广泛用于治疗病毒和细菌感染、炎症以及癌症。黄芪甲苷(AS-IV)是膜荚黄芪水提取物中的主要化合物之一,是一种环阿尔廷型三萜糖苷类化合物。迄今为止,许多细胞和动物模型研究表明,AS-IV在心血管、肺、肾和脑方面具有强大的保护作用。基于过去几十年的研究,本综述系统总结了AS-IV的药理作用、药代动力学和毒性。我们详细分析了AS-IV的神经保护、肝脏保护、抗癌和抗糖尿病药理作用,这归因于其抗氧化、抗炎、抗凋亡特性,以及在增强免疫力、减弱癌细胞迁移和侵袭以及提高化疗药物化疗敏感性方面的作用。此外,还详细介绍了AS-IV与其他中药活性成分或化学药物联合使用的最新进展。这些药理作用与多种信号通路相关,包括Raf-MEK-ERK通路、EGFR-Nrf2信号通路、Akt/PDE3B信号通路、AMPK信号通路、NF-κB信号通路、Nrf2抗氧化信号通路、PI3K/Akt/mTOR信号通路、PKC-α-ERK1/2-NF-κB通路、IL-11/STAT3信号通路、Akt/GSK-3β/β-catenin通路、JNK/c-Jun/AP-1信号通路、PI3K/Akt/NF-κB通路、miRNA-34a/LDHA通路、Nox4/Smad2通路、JNK通路和NF-kB/PPARγ通路。本综述将全面了解黄芪甲苷在神经保护、肝脏保护、抗癌和抗糖尿病方面的药理功能。据此,AS-IV将成为治疗上述疾病的一种有效的替代治疗药物。